Såfremt der er sket brug af ACE- hæmmere fra andet trimester af graviditeten, anbefales ultralydskontrol af nyrefunktionen og kranie.
Should exposure to ACE inhibitor have occurred from the second trimester of pregnancy, ultrasound check of renal function and skull is recommended.